Universitair Ziekenhuis Brussel
Clinical trials sponsored by Universitair Ziekenhuis Brussel, explained in plain language.
-
Brain cancer trial combines immune cells with two immunotherapy drugs to fight recurrence
Disease control OngoingThis study tests a new treatment for people whose glioblastoma (a severe brain cancer) has come back. Doctors inject special immune cells (dendritic cells) and two immunotherapy drugs (ipilimumab and nivolumab) directly into the tumor during surgery, followed by more doses into t…
Phase: PHASE1, PHASE2 • Sponsor: Universitair Ziekenhuis Brussel • Aim: Disease control
Last updated Jun 22, 2026 12:07 UTC
-
New approach aims to ease chronic pain in breast cancer survivors without drugs
Symptom relief OngoingThis study tests whether combining pain neuroscience education (teaching patients about how pain works) with a gradual, timed increase in physical activity can reduce chronic pain in breast cancer survivors. About 122 survivors who have finished cancer treatment will be randomly …
Phase: NA • Sponsor: Universitair Ziekenhuis Brussel • Aim: Symptom relief
Last updated Jun 23, 2026 12:00 UTC
-
New pain block could cut opioid use after mastectomy
Symptom relief TerminatedThis study was designed to compare two methods of pain control after a mastectomy (breast removal surgery): a nerve block called serratus anterior plane block versus local anesthetic injected by the surgeon. The goal was to see which approach reduces the need for strong painkille…
Phase: PHASE4 • Sponsor: Universitair Ziekenhuis Brussel • Aim: Symptom relief
Last updated Jun 16, 2026 12:53 UTC
-
New study aims to ease chronic pain in breast cancer survivors
Symptom relief OngoingThis study looks at whether a combination of pain neuroscience education and motivational interviewing can reduce chronic pain in breast cancer survivors who feel a sense of injustice about their pain. 156 women who have finished primary cancer treatment will be randomly assigned…
Phase: NA • Sponsor: Universitair Ziekenhuis Brussel • Aim: Symptom relief
Last updated Jun 15, 2026 19:05 UTC
-
Virtual reality headsets tested to soothe ECT jitters
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether using a virtual reality (VR) relaxation session can lower anxiety in people about to receive electroconvulsive therapy (ECT). Twenty adults already receiving ECT for depression will try VR relaxation, breathing exercises, or no extra relaxation. Researche…
Phase: NA • Sponsor: Universitair Ziekenhuis Brussel • Aim: Symptom relief
Last updated Jun 11, 2026 12:11 UTC
-
Did storing testicular tissue as a child protect fertility? new study aims to find out
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 50 young men who had cancer or blood disorders as children and received treatments that can harm fertility. Some stored testicular tissue before treatment; others did not. Researchers will check their fertility through exams, ultrasounds, blood tests, and semen…
Phase: NA • Sponsor: Universitair Ziekenhuis Brussel • Aim: Knowledge-focused
Last updated Jun 23, 2026 12:00 UTC
-
Muscle monitor underuse: anesthesiologists share why
Knowledge-focused TerminatedThis study brings together small groups of anesthesiologists from different countries to discuss why muscle monitoring is not used more often during surgery. The goal is to understand the barriers and find ways to increase its use, which could help prevent complications. The stud…
Sponsor: Universitair Ziekenhuis Brussel • Aim: Knowledge-focused
Last updated Jun 22, 2026 11:59 UTC
-
Study on unexplained fevers in elderly withdrawn before starting
Knowledge-focused TerminatedThis study was designed to explore why elderly patients develop fevers that doctors cannot explain. Researchers planned to compare older and younger patients to see if the causes differ and to test newer diagnostic methods. However, the study was withdrawn before enrolling any pa…
Sponsor: Universitair Ziekenhuis Brussel • Aim: Knowledge-focused
Last updated Jun 22, 2026 11:58 UTC
-
Would you swap your Pre-Surgery visit for a video call? hospital asks patients
Knowledge-focused OngoingThis study surveys 200 patients at UZ Brussels who come in for a pre-operative consultation. They are asked if they would be willing to have that consultation remotely via telemedicine instead of face-to-face. The goal is to understand patient receptivity to virtual pre-surgery v…
Phase: NA • Sponsor: Universitair Ziekenhuis Brussel • Aim: Knowledge-focused
Last updated Jun 22, 2026 11:58 UTC
-
ICU artery study pulled before starting
Knowledge-focused TerminatedThis study was designed to measure how stiff the arteries are in intensive care patients receiving drugs to support their heart or blood pressure. The goal was to see if a simple monitor reading could help doctors adjust treatment. However, the study was withdrawn before any pati…
Phase: NA • Sponsor: Universitair Ziekenhuis Brussel • Aim: Knowledge-focused
Last updated Jun 18, 2026 11:52 UTC
-
Eye scans may predict brain decline in heart patients
Knowledge-focused OngoingThis study looks at whether a quick, painless eye scan can help detect early memory and thinking problems in people with atrial fibrillation (AF), a common heart rhythm disorder. Researchers will compare eye images from 40 AF patients with and without mild cognitive impairment to…
Phase: NA • Sponsor: Universitair Ziekenhuis Brussel • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:09 UTC
-
Ovarian tumor genes may reveal who needs stronger treatment
Knowledge-focused OngoingThis study examines genetic mutations in 20 people with serous borderline ovarian tumors, a low-risk type of ovarian growth. Researchers compare tumors with and without implants (spread) to see if certain gene changes predict a higher chance of recurrence. The goal is to learn wh…
Sponsor: Universitair Ziekenhuis Brussel • Aim: Knowledge-focused
Last updated Jun 09, 2026 12:08 UTC
-
Hospital staff antibody levels monitored for a year after AstraZeneca shot
Knowledge-focused OngoingThis study follows 200 hospital employees who received the AstraZeneca COVID-19 vaccine. Researchers measure their antibody levels at 6 weeks, 6 months, and 12 months after the second dose to see how long protection lasts. The goal is to understand the immune response and help gu…
Phase: NA • Sponsor: Universitair Ziekenhuis Brussel • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:17 UTC